We’ve reviewed the transcript of the oral argument in Merck Sharp & Dohme Corp. v. Albrecht, No. 17-290 ..
This isn’t the first time, but the Blog has a problem with its reporting on cases decided in the ongoing ..
Reed Smith’s Life Sciences Health Industry Group will be hosting an upcoming CLE webinar, “The Good, ..
We’ve always hated the Ninth Circuit’s decision in Stengel v. Medtronic Inc., 704 F.3d 1224 (9th ..
We opposed the FDA’s ill-advised 2013 proposal to revamp the process for changing generic drug labeling ..
The FDA has recently released a proposed rule “to establish requirements for the medical device De Novo ..
That is the intriguing title of the latest law review article written by the “Rabbi of Torts,” Prof. ..
As we roll out of bed on the day after Thanksgiving, we are often confronted with contradictory thoughts. ..
Today we have another guest post by long-time friend of the blog, Dick Dean, and his partner at Tucker, ..
An unexpected bit of good news as we go into November. Bexis will be presenting at the Reed Smith ..
A year and a half ago we celebrated a rare prescription drug preemption win in the Philadelphia County ..
This post comes from the Cozen O’Connor side of the blog. Today’s story is about a class action, ..
It would seem to go without saying that for a defendant to be liable for the purported “common-law” ..
If a court acknowledges that no state or federal appellate courts in the jurisdiction have addressed ..
We would be hard pressed to think of a recent judicial decision we have blasted as hard or often as the Third ..
Next week, under pressure from the Drug and Device Law Lifelong Best Friend, we are participating in a “murder ..
We’ve written about a lot of Risperdal summary judgment wins. No medical causation, no warnings causation ..
We recently commented on Sumpter v. Allergan, Inc., 2018 WL 4335519 (E.D. Mo. Sept. 11, 2018), for several ..
We’ll get to today’s case in a moment, but first, a few words about SCOTUS and expiration dates. ..
One of our primary goals is to bring you the latest and greatest news in the drug and device litigation ..